This Article Full Text Full Text (PDF) All Versions of this Article: 34/1/105    most recent 01.STR.0000048865.79221.4Dv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lalouschek, W. Articles by Müllner, M. Search for Related Content PubMed PubMed Citation Articles by Lalouschek, W. Articles by Müllner, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL Medline Plus Health Information Statins Stroke Transient Ischemic Attack Related Collections Lipids Secondary prevention Other Stroke Treatment - Medical Epidemiology

(Stroke. 2003;34:105.)
© 2003 American Heart Association, Inc.

Original Contributions

Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack

Wolfgang Lalouschek, MD; Wilfried Lang, MD; Stefan Greisenegger, MD Marcus Müllner, MD for the Vienna Stroke Study Group

From the University Clinic of Neurology, Clinical Department of Clinical Neurology (W.L., W. Lang, S.G.), and Department of Emergency Medicine (M.M.), University of Vienna Medical School, Vienna, Austria.

Correspondence to Wolfgang Lalouschek, MD, University Clinic of Neurology, Clinical Department of Clinical Neurology, Waehringer Guertel 18-20, 1097, Vienna, Austria. E-mail wolfgang.lalouschek{at}univie.ac.at

Background and Purpose— Statins reduce the risk of myocardial infarction and stroke in patients with vascular disease. Inappropriate serum lipid determination and underuse of statins have been documented in patients with coronary artery disease. Evaluation of hyperlipidemia and treatment with statins in patients with recent ischemic cerebrovascular events have not yet been investigated.

Methods— We determined the frequency of total cholesterol (TC) and low-density lipoprotein cholesterol measurements and the use of statins in a multicenter prospective cohort study of 1743 patients with acute ischemic stroke or transient ischemic attack (TIA). Using multivariate logistic regression analysis, we determined the influence of several clinical variables on lipid measurements and the prescription of statins at hospital discharge.

Results— TC was measured in 90% and low-density lipoprotein cholesterol was measured in 48% of the patients. Differences between the centers accounted for most of the observed variability in a multivariate model. Statin prescription also varied widely between the centers. The prescription of a statin at discharge was most strongly associated with statin intake before the event and with increasing TC levels; elderly patients received statins less often. Coronary artery disease, peripheral artery disease, and other manifestations of atherosclerosis were not independently associated with the use of statins; 68% of the patients with manifest atherosclerosis and TC levels >200 mg/dL were discharged without a statin.

Conclusions— The determination of serum lipid profiles varies widely between different centers. Statins are highly underused in patients with recent ischemic stroke or TIA, particularly in those in whom statins are indicated according to existing recommendations (eg, patients with additional coronary artery disease and hypercholesterolemia). Currently, international guidelines concerning the use of statins are not adequately implemented in clinical practice in patients with stroke or TIA.

Key Words: lipids • prevention • statins • stroke

This article has been cited by other articles:

				T Warnecke, I Teismann, W Meimann, S Olenberg, J Zimmermann, C Kramer, E B Ringelstein, W R Schabitz, and R Dziewas Assessment of aspiration risk in acute ischaemic stroke--evaluation of the simple swallowing provocation test J. Neurol. Neurosurg. Psychiatry, March 1, 2008; 79(3): 312 - 314. [Abstract] [Full Text] [PDF]

				A. P. Levine, D. P. Mikhailidis, T. Moross, K. Benson, and M. Gor Achieving Vascular Risk Factor Targets: A Survey of a London General Practice Angiology, March 1, 2008; 59(1): 36 - 46. [Abstract] [PDF]

				E. E. Smith, A. R. Abdullah, H. Amirfarzan, and L. H. Schwamm Serum lipid profile on admission for ischemic stroke: Failure to meet National Cholesterol Education Program Adult Treatment Panel (NCEP-ATPIII) guidelines Neurology, February 27, 2007; 68(9): 660 - 665. [Abstract] [Full Text] [PDF]

				A. J. Mullard, M. J. Reeves, B. S. Jacobs, R. U. Kothari, G. L. Birbeck, K. Maddox, S. Stoeckle-Roberts, S. Wehner, and Paul Coverdell National Acute Stroke Registry Mich Lipid Testing and Lipid-Lowering Therapy in Hospitalized Ischemic Stroke and Transient Ischemic Attack Patients: Results From a Statewide Stroke Registry Stroke, January 1, 2006; 37(1): 44 - 49. [Abstract] [Full Text] [PDF]

				B. Ovbiagele, C. S. Kidwell, and J. L. Saver Expanding Indications for Statins in Cerebral Ischemia: A Quantitative Study Arch Neurol, January 1, 2005; 62(1): 67 - 72. [Abstract] [Full Text] [PDF]

				A. Villa, E. Fabris, and O. Milani Determination of Lipid Profile in Patients With Ischemic Stroke or Transient Ischemic Attack Stroke, July 1, 2003; 34 (7): e77 - e77. [Full Text] [PDF]